Cargando…

Natural Killer Cell–mediated Lysis of Autologous Cells Modified by Gene Therapy

This study investigated the role of natural killer (NK) cells as effectors of an immune response against autologous cells modified by gene therapy. T lymphocytes were transduced with LXSN, a retroviral vector adopted for human gene therapy that carries the selectable marker gene neo, and the autolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liberatore, Concetta, Capanni, Marusca, Albi, Nicola, Volpi, Isabella, Urbani, Elena, Ruggeri, Loredana, Mencarelli, Amedea, Grignani, Francesco, Velardi, Andrea
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1999
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192959/ https://www.ncbi.nlm.nih.gov/pubmed/10377181

Ejemplares similares

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
por: Böhm, M., et al.
Publicado: (1994)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Tumorigenicity and lysis by natural killers
Publicado: (1981)

Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes
Publicado: (1982)

Fractalkine Expression Induces Endothelial Progenitor Cell Lysis by Natural Killer Cells
por: Todorova, Dilyana, et al.
Publicado: (2011)

Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals
por: Fogli, Manuela, et al.
Publicado: (2008)

The Evolution of T Cell Depleted Haploidentical Transplantation
por: Aversa, Franco, et al.
Publicado: (2019)

Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
por: Parisi, Sarah, et al.
Publicado: (2022)

Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes
Publicado: (1985)

BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
por: Frazao, Alexandra, et al.
Publicado: (2020)

Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor
Publicado: (1982)

Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells
por: Tseng, Han-Ching, et al.
Publicado: (2010)

Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
por: Schellhorn, Melina, et al.
Publicado: (2015)

Correction: BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
Publicado: (2021)

Characterization of the killer cell generated in the autologous mixed leukocyte reaction
Publicado: (1983)

In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma
por: Matera, Lina, et al.
Publicado: (2006)

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I
por: Yang, Guang, et al.
Publicado: (2015)

The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid
por: Alexander, C L, et al.
Publicado: (1999)

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
por: Sangiolo, Dario, et al.
Publicado: (2014)

Transfection of a rat cell line with the v-Ki-ras oncogene is associated with enhanced susceptibility to natural killer cell lysis
Publicado: (1985)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Lysis of Fresh Human Tumor Cells by Autologous Peripheral Blood Lymphocytes and Tumor‐infiltrating Lymphocytes Activated hy PSK
por: Kariya, Yoshitaka, et al.
Publicado: (1991)

Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
por: Limongello, Roberto, et al.
Publicado: (2021)

A flow cytometric assay for the quantification of MSC lysis by peripheral blood mononucleated cells
por: Chieregato, Katia, et al.
Publicado: (2021)

Post-cytokine-release Salt Wasting as Inverse Tumor Lysis Syndrome in a Non-cerebral Natural Killer-cell Neoplasm
por: Ariizumi, Hirotsugu, et al.
Publicado: (2017)

Interferon Gamma Induces Changes in Natural Killer (NK) Cell Ligand Expression and Alters NK Cell-Mediated Lysis of Pediatric Cancer Cell Lines
por: Aquino-López, Arianexys, et al.
Publicado: (2017)

Tumour necrosis factor-alpha induces an increase in susceptibility of human glioblastoma U87-MG cells to natural killer cell-mediated lysis.
por: Kondo, S., et al.
Publicado: (1994)

HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response
por: Ward, Jeffrey, et al.
Publicado: (2009)

Expanding the Clinical Spectrum of Sotos Syndrome in a Patient with the New “c.[5867T>A]+[=]”; “p.[Leu1956Gln]+[=]” NSD1 Missense Mutation and Complex Skin Hamartoma
por: Mencarelli, Annalisa, et al.
Publicado: (2018)

Lysis of antibody-coated cells by platelets
Publicado: (1982)

Shape-Dependent Optoelectronic Cell Lysis**
por: Kremer, Clemens, et al.
Publicado: (2014)

NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily
por: Cantoni, Claudia, et al.
Publicado: (1999)

Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway
por: Pan, Jie, et al.
Publicado: (2017)

Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions
por: Haspels, Heleen Neeltje, et al.
Publicado: (2018)

Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis
Publicado: (1985)

Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
por: Markel, Gal, et al.
Publicado: (2009)

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
por: Wang, Zibing, et al.
Publicado: (2016)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
por: Laeremans, Thessa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_517v68j71dpkg7i854pnp50q8h